1005515-10-5

Basic information

• Product Name: 4-[5-(1,1-Dimethoxyethyl)-2-methoxy-3-trifluoromethylphenyl]morpholine
• Synonyms: 4-[5-(1,1-Dimethoxyethyl)-2-methoxy-3-trifluoromethylphenyl]morpholine
• CAS NO: 1005515-10-5
• Molecular Weight: 349.35
• Mol File: 1005515-10-5.mol

Chemical Properties

• CAS DataBase Reference: 4-[5-(1,1-Dimethoxyethyl)-2-methoxy-3-trifluoromethylphenyl]morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[5-(1,1-Dimethoxyethyl)-2-methoxy-3-trifluoromethylphenyl]morpholine(1005515-10-5)
• EPA Substance Registry System: 4-[5-(1,1-Dimethoxyethyl)-2-methoxy-3-trifluoromethylphenyl]morpholine(1005515-10-5)

Safety Data

• Hazardous Substances Data: 1005515-10-5(Hazardous Substances Data)

Upstream product

• 1005515-08-1 1-(3-Bromo-4-hydroxy-5-trifluoromethylphenyl)ethanone 
• 149105-11-3 1-[4-hydroxy-3-(trifluoromethyl)phenyl]ethan-1-one 
• 110-91-8 morpholine 
• 1005515-09-2 1-Bromo-5-(1,1-dimethoxyethyl)-2-methoxy-3-trifluoromethylbenzene 

Downstream Products

• 1005515-11-6 2-bromo-1-(4-methoxy-3-morpholin-4-yl-5-trifluoromethylphenyl)ethanone 

Relevant articles and documents

TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The i

TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where X, A?, Q1, Q2 Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated recepto

IMINO-IMIDAZO-PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY

The invention relates to compounds of the formula I having antithrombotic activity, which in particular inhibit the protease-activated receptor 1 (PAR1), processes for their preparation and use thereof as medicaments.